NCT Number: NCT05176483
Phase: Phase 1
Trial Summary: This is a multicenter Phase 1b, open label, dose-escalation and cohort-expansion study, evaluating the safety, tolerability, PK, preliminary antitumor activity, and effect of bioma – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Exelixis
Acronym: STELLAR-002
Study of XL092 in Combination With Immuno-Oncology Agents in Subjects With Solid Tumors
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives